Page last updated: 2024-09-05

tolvaptan and Cyst

tolvaptan has been researched along with Cyst in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (22.22)24.3611
2020's7 (77.78)2.80

Authors

AuthorsStudies
Cao, X; Fang, Q; Fu, K; Guo, D; He, Y; Liu, H; Su, L; Wang, J; Wang, P; Xie, Y; Xiong, X; Xu, P; Yin, L; Yuan, H; Zhang, H; Zhu, X1
Hasegawa, E; Hoshino, J; Ikuma, D; Mizuno, H; Sawa, N; Sekine, A; Suwabe, T; Ubara, Y; Yamanouchi, M1
Reiterová, J; Tesař, V1
Aihara, M; Fujiki, H; Hattori, K; Isakari, Y; Mizuguchi, H; Nagano, K; Ohmoto, K; Takeshita, Y; Yamada, Y; Yamamoto, M; Yamamura, Y1
Cadnapaphornchai, MA; Goldstein, SL; Greenbaum, LA; Guay-Woodford, LM; Liebau, MC; Litwin, M; Mekahli, D; Schaefer, F; Seeman, T1
Bange, H; Dijkstra, KL; Kanhai, AA; Leonhard, WN; Peters, DJM; Price, LS; Verburg, L1
Gaur, P; Gedroyc, W; Hill, P1
Kitajima, M; Miura, S; Takenaka, T1
Fujiki, H; Nivens, E; Pinto, CS; Reif, GA; Wallace, DP; Yamaguchi, T1

Reviews

2 review(s) available for tolvaptan and Cyst

ArticleYear
Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment.
    International journal of molecular sciences, 2022, Mar-19, Volume: 23, Issue:6

    Topics: Animals; Apoptosis; Cysts; Humans; Phosphatidylinositol 3-Kinases; Polycystic Kidney, Autosomal Dominant; Tolvaptan

2022
ADPKD-what the radiologist should know.
    The British journal of radiology, 2019, Volume: 92, Issue:1098

    Topics: Antidiuretic Hormone Receptor Antagonists; Carcinoma, Renal Cell; Cysts; Diagnosis, Differential; Diagnostic Imaging; Disease Progression; Humans; Kidney Calculi; Kidney Neoplasms; Polycystic Kidney, Autosomal Dominant; Tolvaptan

2019

Other Studies

7 other study(ies) available for tolvaptan and Cyst

ArticleYear
Benzodiazepine Derivatives as Potent Vasopressin V
    Journal of medicinal chemistry, 2022, 07-14, Volume: 65, Issue:13

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzodiazepines; Cyclic AMP; Cysts; Humans; Kidney; Mice; Polycystic Kidney, Autosomal Dominant; Receptors, Vasopressin; Vasopressins

2022
Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use.
    PloS one, 2022, Volume: 17, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Case-Control Studies; Cysts; Female; Humans; Kidney; Liver; Liver Diseases; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Prognosis; Retrospective Studies; Tolvaptan

2022
[Tolvaptan, a vasopressin V
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2022, Volume: 157, Issue:4

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Cyclic AMP; Cysts; Polycystic Kidney, Autosomal Dominant; Tolvaptan; Vasopressins

2022
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.
    BMC nephrology, 2023, 02-13, Volume: 24, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Child; Cysts; Humans; Infant, Newborn; Kidney; Longitudinal Studies; Polycystic Kidney, Autosomal Dominant; Polycystic Kidney, Autosomal Recessive; Tolvaptan

2023
Renal cyst growth is attenuated by a combination treatment of tolvaptan and pioglitazone, while pioglitazone treatment alone is not effective.
    Scientific reports, 2020, 02-03, Volume: 10, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Cell Culture Techniques; Combined Modality Therapy; Cysts; Disease Progression; Humans; Kidney; Male; Mice; Pioglitazone; Polycystic Kidney, Autosomal Dominant; PPAR gamma; Rats; Rats, Wistar; Tolvaptan

2020
The management of polycystic liver disease by tolvaptan.
    Clinical and molecular hepatology, 2020, Volume: 26, Issue:1

    Topics: Abdomen; Adult; Antidiuretic Hormone Receptor Antagonists; Cysts; Female; Humans; Kidney; Liver; Liver Diseases; Tolvaptan; Tomography, X-Ray

2020
Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.
    American journal of physiology. Renal physiology, 2011, Volume: 301, Issue:5

    Topics: Adult; Aged; Amiloride; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blotting, Western; Cell Proliferation; Cells, Cultured; Chlorides; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Cysts; Diuretics; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Agents; Tolvaptan; Vasopressins

2011